Organism name | Larix kaempferi (Lamb.) Carr |
---|---|
Genus | Larix |
Family | Pinaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Larix |
---|---|
Linked NCBI taxonomy ID | 3325 |
Linked level | genus |
Family in NCBI taxonomy | Pinaceae |
---|---|
ID | 3318 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Spermatophyta |
---|---|
ID | 58024 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00023770
![]() |
Sitosterol
/ Stigmasta-5,22-dien-3beta-ol / (24R)24-Ethylcholesta-5,22-dien-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
![]() |
||
C00029821
![]() |
Sitostenone
/ beta-Sitostenone / Stigmast-4-en-3-one / Stigmast-4-ene-3-one |
CHEMBL66926
|
No. 53 | No. 11 |
![]() |
|||
C00041127
![]() |
Stigmastan 3,6-dione
|
No. 68 | No. 11 |
![]() |
||||
C00041128
![]() |
Stigmastan-3-one
|
No. 68 | No. 11 |
![]() |
||||
C00003747
![]() |
Friedelin
/ Friedeline / Friedelanone / (-)-Friedelin / Friedelan-3-one |
CHEMBL485998
CHEMBL1551590 |
C060796
|
2 / 0 / 0 | No. 101 | No. 52 |
![]() |
|
C00035217
![]() |
24-Methylenecycloartanone
/ 3-Oxo-24-methylenecycloartane |
CHEMBL376835
|
No. 129 | No. 11 |
![]() |
|||
C00003661
![]() |
24-Methylenecycloartanol
/ 24-Methylenecycloartan-3beta-ol |
CHEMBL121329
CHEMBL376350 |
C066041
|
No. 129 | No. 11 |
![]() |
||
C00040804
![]() |
24-Methylenecycloartan-3-one
|
CHEMBL376835
|
No. 129 | No. 11 |
![]() |
|||
C00020065
![]() |
alpha-Cadinol
/ (-)-alpha-Cadinol |
CHEMBL486795
|
No. 205 | No. 38 |
![]() |
|||
C00022713
![]() |
Larixol
|
CHEMBL1370284
|
5 / 7 / 37 | No. 256 | No. 46 |
![]() |
||
C00040773
![]() |
16-nor-15-Oxoabieta-8,11,13-trien-18-oic acid
|
No. 323 | No. 41 |
![]() |
||||
C00040763
![]() |
12,15-Dihydroxyabieta-8,11,13-trien-18-oic acid
|
No. 323 | No. 41 |
![]() |
||||
C00040858
![]() |
Abieta-8,11,13,15-tetraen-18-oic acid
|
No. 323 | No. 41 |
![]() |
||||
C00020240
![]() |
Oplopanone
/ (-)-Oplopanone |
No. 1395 |
![]() |
|||||
C00041092
![]() |
Rheosmin
|
CHEMBL105912
|
C035522
|
1 / 3 / 4 | 1 / 1 | No. 5516 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00022713 C00023770 | 0 / 1 |
P00734 | Prothrombin | S1A | C00023770 | 4 / 2 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00022713 | 7 / 37 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00023770 | 2 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00023770 | 0 / 0 |
Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00003747 | 0 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00023770 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00023770 | 3 / 2 |
P08183 | Multidrug resistance protein 1 | drug | C00023770 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00023770 | 0 / 1 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00023770 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00022713 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00023770 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00023770 | 4 / 2 |
Q96RI1 | Bile acid receptor | NR1H4 | C00003747 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00022713 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00023770 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00023770 | 1 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00022713 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00023770 | 1 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00023770 | 1 / 0 |
P10275 | Androgen receptor | NR3C4 | C00041092 | 3 / 4 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00023770 | 1 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00023770 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00041092
|
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#211980 | Lung cancer |
P04637
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P00734
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
KEGG | name | UniProt |
---|---|---|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|